Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | INCA32459 |
Synonyms | |
Therapy Description |
INCA32459 is a bispecific antibody that targets both PD-1 (PDCD1) and LAG3, potentially leading to increased antitumor immune response and inhibition of tumor growth (Journal for ImmunoTherapy of Cancer 2022;10). |